All three improve glycemic control, insulin sensitivity, and cardiovascular risk markers and GLP-1 peptides demonstrate serious longevity potential well beyond what is acknowledged by mainstream medicine
Pickart estimated lethal dose at approximately 22,500 mg for humans (300-fold above effective doses), with animal LD50 studies in mice showing 8 mg per 25g mouse (320 mg/kg, translating to ~22,400 mg for 154 lb human)
Then we discuss the factors affecting stages of neurogenesis and the interplay between neural stem cells (NSCs) and neurogenic niche under AD pathological conditions
Microbiota-derived butyrate limits the autoimmune response by promoting the differentiation of follicular regulatory T cells
What we are developing could be used as something like maintenance therapy where you could get subcutaneous injections every 3 to 6 months. The market opportunity also resulted in a dramatic legal battle between Pfizer and Novo Nordisk last year, when the two companies fought over buying Metsera, a start-up developing weight-loss drugs
